Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00973479 · ClinicalTrials.gov registry record · Phase 3
An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy
A Phase 3 study, sponsored by Centocor.
- Completed
- Registry status
- Phase 3
- Development phase
- 592
- Enrollment target
NCT00973479 is a Phase 3 study that has completed, run by Centocor. The registered enrollment target is 592 participants.
The verdict
NCT00973479, a Phase 3 study, has completed, sponsored by Centocor.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 592 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate clinical effectiveness and safety of golimumab with methotrexate (MTX) in the treatment of rheumatoid arthritis (RA) when compared to MTX alone.
Interventions
- OTHER Placebo
- DRUG Golimumab
- DRUG methotrexate (MTX)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 592 participants |
| Start Date | 2009-09 |
| Est. Completion | 2013-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00973479
The ClinicalTrials.gov registry entry for NCT00973479 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 592 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centocor, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00973479 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00973479 about?
NCT00973479 is a clinical study titled "An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy". The purpose of this study is to evaluate clinical effectiveness and safety of golimumab with methotrexate (MTX) in the treatment of rheumatoid arthritis (RA) when compared to MTX alone.
What is the current status of trial NCT00973479?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 592 participants. The study started on 2009-09. Estimated completion is 2013-02.
What interventions are being tested in trial NCT00973479?
The interventions under investigation include: Placebo (OTHER), Golimumab (DRUG), methotrexate (MTX) (DRUG).
Who is sponsoring clinical trial NCT00973479?
This trial is sponsored by Centocor, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.